Edition:
United States

North China Pharmaceutical Co Ltd (600812.SS)

600812.SS on Shanghai Stock Exchange

4.89CNY
25 May 2018
Change (% chg)

¥-0.04 (-0.81%)
Prev Close
¥4.93
Open
¥4.92
Day's High
¥4.92
Day's Low
¥4.88
Volume
224,100
Avg. Vol
5,086,141
52-wk High
¥6.58
52-wk Low
¥4.11

Chart for

About

North China Pharmaceutical Co., Ltd. is a China based company principally engaged in the research and development, production and sales of pharmaceuticals. The Company is mainly engaged in the research and development, production and sales of chemical raw materials, chemical preparations, biological preparations, pharmaceutical... (more)
No analyst recommendations are available for .

Overall

Beta: 0.97
Market Cap(Mil.): ¥8,072.48
Shares Outstanding(Mil.): 1,630.81
Dividend: 0.01
Yield (%): 0.40

Financials

  600812.SS Industry Sector
P/E (TTM): 254.63 28.26 32.60
EPS (TTM): 0.02 -- --
ROI: 0.36 13.20 12.74
ROE: 0.59 14.98 14.66

BRIEF-North China Pharmaceutical receives GMP certificate

* Says it received goods manufacture practice (GMP) certificate from Hebei Food and Drug Administration

Feb 12 2018

BRIEF-North China Pharmaceutical receives GMP certificate

* Says it received goods manufacture practice (GMP) certificate from Hebei Food and Drug Administration on Feb. 6

Feb 08 2018

BRIEF-North China Pharmaceutical sees FY 2017 net profit down 50 pct to 70 pct

* Sees FY 2017 net profit to decrease by 50 percent to 70 percent, or to decreased by 27 million yuan to 38 million yuan

Jan 31 2018

Earnings vs. Estimates